← Back to Search

Serotonin-Norepinephrine Reuptake Inhibitor

1 for Post-Traumatic Stress Disorder

Phase 3
Waitlist Available
Led By Jose M Canive, M.D.
Research Sponsored by Canive, Jose M., M.D.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, weeks 1, 2, 4, 8, & 12
Awards & highlights

Study Summary

The purpose of this study is to determine whether Duloxetine (Cymbalta®) is an effective treatment in reducing the symptoms of Posttraumatic Stress Disorder (PTSD).

Eligible Conditions
  • Post-Traumatic Stress Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, weeks 1, 2, 4, 8, & 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, weeks 1, 2, 4, 8, & 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
PTSD Symptoms will be assessed by the Clinician-Administered PTSD Scale for DSM-IV (CAPS)
Secondary outcome measures
Visual Analog Scale for Pain (VAS)

Side effects data

From 2008 Phase 4 trial • 339 Patients • NCT00422162
22%
Nausea
16%
Headache
5%
Hyperhidrosis
5%
Constipation
5%
Dry mouth
4%
Diarrhoea
2%
Insomnia
2%
Suicidal ideation
2%
Nasopharyngitis
2%
Tremor
2%
Suicide attempt
1%
Irritability
1%
Self injurious behaviour
1%
Back pain
100%
80%
60%
40%
20%
0%
Study treatment Arm
Duloxetine (60 mg)
Duloxetine (120 mg)

Trial Design

1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
Open-label Study
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Duloxetine
FDA approved

Find a Location

Who is running the clinical trial?

Canive, Jose M., M.D.Lead Sponsor
Eli Lilly and CompanyIndustry Sponsor
2,618 Previous Clinical Trials
3,201,497 Total Patients Enrolled
Jose M Canive, M.D.Principal InvestigatorNew Mexico VA Healthcare System

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What site did they apply to?
New Mexico VA Health Care System
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Open-Label Duloxetine Monotherapy in the Treatment of Posttraumatic Stress Disorder
2005. "Open-Label Duloxetine Monotherapy in the Treatment of Posttraumatic Stress Disorder". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00583193.
All > Trauma
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top